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Abstract: There has been a recent surge of interest in the use of superparamagnetic iron oxide
nanoparticles (SPIONs) as contrast agents (CAs) for magnetic resonance imaging (MRI), due to their
tunable properties and their low toxicity compared with other CAs such as gadolinium. SPIONs exert
a strong influence on spin-spin T2 relaxation times by decreasing the MR signal in the regions to which
they are delivered, consequently yielding darker images or negative contrast. Given the potential of
these nanoparticles to enhance detection of alterations in soft tissues, we studied the MRI response of
hydrophobic or hydrophilic SPIONs loaded into liposomes (magnetoliposomes) of different lipid
composition obtained by sonication. These hybrid nanostructures were characterized by measuring
several parameters such as size and polydispersity, and number of SPIONs encapsulated or embedded
into the lipid systems. We then studied the influence of acyl chain length as well as its unsaturation,
charge, and presence of cholesterol in the lipid bilayer at high field strength (7 T) to mimic the
conditions used in preclinical assays. Our results showed a high variability depending on the nature
of the magnetic particles. Focusing on the hydrophobic SPIONs, the cholesterol-containing samples
showed a slight reduction in r2, while unsaturation of the lipid acyl chain and inclusion of a negatively
charged lipid into the bilayer appeared to yield a marked increase in negative contrast, thus rendering
these magnetoliposomes suitable candidates as CAs, especially as a liver CA.
Keywords: magnetoliposomes; hydrophobic Super Paramagnetic Iron Oxide Nanoparticles (SPIONs);
Magnetic Resonance Imaging (MRI); relaxivities; contrast agents
1. Introduction
Magnetic resonance imaging (MRI) is one of the most powerful noninvasive imaging techniques in
diagnostic radiology, due to its high soft tissue contrast, spatial resolution, and penetration depth [1–4].
The magnetic fields employed MRI for clinical diagnosis are of 3 T, but preclinical studies with small
animal models, which need the highest possible resolution, rely on very high field strengths (>7 T).
Despite the relatively high quality of the MR images of the soft tissues, in some cases it is not possible
to have enough image contrast to diagnose the pathology of interest. In these cases, a contrast agent
(CA) is needed. The CA improves the contrast-to-noise ratio in MRI by shortening the spin-lattice T1
and/or spin-spin T2 relaxation times of the water protons within the tissues/regions of interest, thus
enhancing the image contrast. Therefore, what is imaged is not the agent of contrast, but rather its effect
on the relaxivity of the adjacent water protons, predominantly through the dipolar interaction [5]. The
increase of MRI contrast produced by the magnetic nanoparticles is dependent on their composition,
size, surface properties, and of the extent of aggregation in the biological milieu [6,7]. The efficiency of
a CA depends on its r1 and r2 relaxivity as well as their ratio. The higher the ratio of r2/r1, the better
the efficiency of a T2 CA and vice versa for a T1 CA [8,9]. Paramagnetic substances, such as gadolinium
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(Gd), are positive contrast agents (T1 CA). They enhance the MR signal intensity. However, they
present two clinical limitations: Gd complexes have a certain degree of toxicity, and their efficiency at
higher magnetic fields decreases. Due to these limitations, the research focus has shifted to negative
CA such as superparamagnetic iron oxide nanoparticles (SPIONs). As compared to gadolinium
compounds, SPIONs show the advantages of tunable size and shape, as well as possibility of surface
modification and more effectiveness at lower concentrations because of their superparamagnetic
property. SPIONs decrease the MR signal intensity of the regions where they are delivered and thus
those regions appear darker in the image. Magnetite (Fe3O4) and maghemite (γ-Fe2O3) are two
types of SPIONs, easily prepared in the laboratory, that have been used for biomedical applications
since they meet the following criteria: (1) chemical stability under physiological conditions; (2) low
toxicity and (3) high magnetic moments [10]. There are several formulations of SPIONs that have been
approved by the U. S. Food and Drug Administration (FDA) and the European Medicines Agency
(EMEA) for clinical use as MRI CA [11]. However, the majority of the approved compounds are,
at present, out of the market [12]. The SPIONs for biomedical applications are usually prepared by
hydrolytic methods, mainly by alkaline co-precipitation of stoichiometric amounts of Fe(II) and Fe(III).
Such methods yield hydrophilic but usually polydisperse nanoparticles, and, in consequence, the
nanoparticles can form large agglomerates in physiological media. Therefore, small well-defined
SPIONs with a narrow distribution are of great interest, since magnetic properties change drastically
with particle size. The thermal decomposition of metal precursors in organic media, a non-hydrolytic
method, produces high-quality SPIONs with uniform size and high crystallinity. However, these
SPIONs are hydrophobic. To achieve the necessary stability in aqueous media, the modification of their
surface is required. Several methods based on the modification of the surface have been developed;
ligand exchange with water-dispersible ligands and the encapsulation of ligands are two of the most
representative strategies of such modification [7,13].
Considering the fact that phospholipids present several advantages such as biocompatibility,
biodegradability, and reduced toxicity, liposomes can be used as a coating for the SPIONs. Combining
nanoparticles with liposomes is a highly elaborative methodology in the emerging fields of
nanomedicine and nanobiotechnology, since liposomes can carry on either hydrophobic or hydrophilic
nanoparticles. SPIONs can be hybridized with liposomes to get magnetoliposomes (MLs; for a review
on MLs, see [14,15]). MLs have been used as CA for molecular imaging and as a theranostic tool [16–20],
but mainly as an efficient MRI CA with enhancing T2 contrast, although some groups have combined
the T1 and T2 MRI CA in an unique system to obtain bimodal CA [16].
The magnetic properties of SPIONs depend on various factors, such as size, shape, composition,
and crystallinity [11]. In this way, the proton relaxivity shows a strong dependence on the particles
size. Moreover, according to the Koening–Kellar model [21] the types of surface functionalization
and hydrophilicity influence the longitudinal (r1) and the transversal (r2) relaxivities. Therefore, the
coating of magnetic nanoparticles greatly modifies the MRI contrast, either hampering the diffusion of
water molecules, or forming hydrogen bonds with water molecules, thus increasing the residence time
of water [22]. Hence, the measured proton relaxation rates depend strongly on the hydrophilic nature
of the coating layer.
Since liposomes can be made with different lipid formulations and can present several sizes and
physical structures depending on the method of preparation, the coatings and structures interacting
with SPIONs will be different.
To improve the knowledge about the magnetic relaxation associated with the contrast produced
by MLs, we have studied the impact that the sonication process has on the relaxivity of liposomes
obtained by this method. To achieve this, we have used hydrophilic and hydrophobic magnetic
particles encapsulated in liposomes. Liposomes were made of six formulations, differing in the
fatty-acid chain length, the presence or absence of cholesterol (CHOL), and the presence or absence of
negative charge (afforded by phosphatidylserine, (PS)). After sonication, the relaxivity properties of
such hybrid nanoparticles were determined at 7 T.
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2. Results and Discussion
2.1. Characteristics
Size of different samples of MLs was determined by dynamic light scattering (DLS). A single
population (monomodal distribution) constituted all MLs samples, with a z-diameter ranging from
220 nm to 335 nm. Polydispersity index was between 0.200 and 0.300. The size and polydispersity of
such populations are strongly dependent on the sonication process. For making the comparison among
the different samples possible, the conditions of the sonication process were kept invariably constant.
After gel exclusion chromatography (GEC) purification, the lipid and the iron content were determined
and the encapsulation efficiency was calculated as µmol of iron by mmol of lipid (Table 1). The volume
accessible to the ferrofluid can explain the great difference observed in the encapsulation efficiency
of liposomes containing hydrophilic or hydrophobic ferrofluid. While hydrophilic ferrofluid can be
distributed either inside the aqueous interior of liposomes or in the external medium, the hydrophobic
one can only be located in or near the lipid double layer. Consequently, the hydrophilic ferrofluid is
encapsulated in liposomes to a lesser extent than the hydrophobic magnetic core. This also implies
that the GEC purification is applied exclusively to the liposomal formulations containing hydrophilic
nanoparticles.
Table 1. Encapsulation efficiency, average of cross-sectional area, and number (N) of magnetic
hydrophilic (H) and hydrophobic (O) nanoparticles encapsulated into liposomes of different lipid
composition. MLs: Magnetoliposomes; DMPC: 1,2-Dimyristoyl-sn-glicerol-3 phosphatidylcholine;
DOPC: 1,2-Dioleyl-sn-glicerol-3 phosphatidylcholine; CHOL: Cholesterol and PS: Phosphatidylserine.
MLs Encapsulation Efficiency/µmol Magnetite Average Cross-Sectional Area/nm2 N
H-DMPC 6.9 0.59 3
O-DMPC 43.6 0.59 16
O-DMPC-CHOL 22.8 0.51 11
O-DMPC-PS 20.4 0.63 10
H-DOPC 7.9 0.72 2
O-DOPC 274.0 0.72 17
O-DOPC:CHOL 49.0 0.60 15
O-DOPC-PS 17.7 0.71 9
On the other hand, the number of magnetic nanoparticles encapsulated in each liposome N can be
calculated with the data of the final concentrations of magnetite and lipid (Table 1). N was determined
from the ratio of the total number of magnetic nanoparticles NMNP and lipid vesicles NVES.
N “ NMNP
NVES
(1)
NMNP and NVES have been obtained from nanoparticle size and concentration, respectively
through the following equations:
NMNP “ MNPdNPVNP (2)
NVES “ NVOLNlipid (3)
where MNP is the total mass of Fe3O4 as obtained from colorimetric determination, dNP is the density
of magnetite (dNP = 5.1 g¨ cm´3). VNP is the volume of a single nanoparticle taking a diameter of 5 nm
and considering nanoparticles as perfect spheres (VNP = 65.45 nm3).
Assuming that liposomes are unilamellar, for a large spherical liposome higher than 200 nm,
the inner and the outer layers have the same surface and thus contain the same amount of lipids.
From the average radius of each liposomal sample, the total area can be calculated. Dividing
this total area by the cross-sectional area of 1,2-Dioleyl-sn-glicerol-3 phosphatidylcholine (DOPC)
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molecules (ao = 0.72 nm2) [23], 1,2-Dimyristoyl-sn-glicerol-3 phosphatidylcholine (DMPC) molecules
(ao = 0.59 nm2) [24], PS molecules (ao = 0.70 nm2) [25] and CHOL molecules (ao = 0.35 nm2) [26], the
number of lipid molecules per vesicle (Nlipid) can be calculated. An average cross-sectional area was
used when liposomes were formed by more than one lipid (Table 1). Multiplying the lipid concentration
of samples after GEC step by the Avogadro constant, the number of total lipids molecules (NVOL) by
unit of volume can be obtained. From NMNP and NVES, the number of encapsulated magnetic particles
by liposome can be determined (Equation (1)).
Table 1 shows that the number of encapsulated magnetic particles is higher in liposomes
containing hydrophobic particles than those encapsulating hydrophilic ones. When hydrophilic
nanoparticles are used, their size is increased by the presence of the attached water molecules leading
to an average hydrodynamic diameter of 20 nm. In consequence, the number of encapsulated
nanoparticles inside the aqueous volume of a liposome is limited. Moreover, this encapsulation
is based on random trapping by bilayer membrane closure. Thus, sorting as a function of intravesicle
loading is usually a tricky problem. In the case of hydrophobic nanoparticles, these have a higher
affinity to the acyl-chains confined in the hydrophobic interior of the phospholipid bilayer. However,
we must take into account that the magnetic particles are 5 nm in size, and the average thickness of the
bilayer ranges from 3.5 to 5 nm. For this reason, hydrophobic nanoparticles can sometimes project
out of the bilayer (Figure 1A) or be embedded within two neighboring bilayers (Figure 1B). A third
possibility is the formation of micelle-like assemblies (Figure 1C) by adsorption of phospholipids on
the nanoparticle. The formation of the original MLs followed this strategy [27], although the size of
the nanoparticles used was higher. A size of 5 nm, corresponding to the employed nanoparticles,
involves a high curvature, and this would induce the creation of a large free volume between the
acyl-chains of the monolayer. As can be observed in microscopy images, no free particles are observed.
Hence, we only contemplated the two first possibilities. The embedding of a hydrophobic particle in a
hydrophobic membrane is energetically favorable since it is the difference between a favorable Gibbs
energy change produced by moving a hydrophobic particle from pure water into the bilayer and the
energy needed to deform the hydrophobic membrane [28,29].
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bilayers (A,B) or monolayers (micelle-like-assemblies as depicted in C). 
In Figure 2 TEM images of ML structures are showed. Some liposomes are in close contact, 
perhaps by merging of neighboring bilayers. Bilayer merging was probably driven by the interfacial 
activity of the nanoparticles, the energy gain by a hydrophobic surface partitioning from water into 
a hydrophobic environment. 
Cryo-TEM was used to verify nanoparticle loading and its effect on liposomal structure (Figure 3). 
Figure 3A,B confirm that hydrophobic nanoparticles are incorporated into the lipid bilayer. The high 
contrast of magnetic nanoparticles made visualization of the bilayer extremely difficult. However, 
the disposition of the nanoparticles in circular structures not would be observed if nanoparticles were 
not embedded into the bilayer. It is known that nanoparticles can disrupt vesicle formation under 
certain conditions, for example, when the diameter of hydrophobic nanoparticles is well above the 
Figure 1. Location of the hydrophobic magnetic particle in the liposome: (A) Projected out of the
bilayer; (B) embedded within neighboring bilayers and; (C) formation of micelle-like assemblies.
Hydrophobic nanoparticles are represented by a dark blue circle whereas the phospholipids are the
light blue parts (polar head joined to a two acyl chains). In a water milieu, phospholipids can form
bilayers (A,B) or monolayers (micelle-like-assemblies as depicted in C).
In Figure 2 TEM images of ML structures are showed. Some liposomes are in close contact,
perhaps by merging of neighboring bilayers. Bilayer merging was probably driven by the interfacial
activity of the nanoparticles, the energy gain by a hydrophobic surface partitioning from water into a
hydrophobic environment.
Cryo-TEM was used to verify nanoparticle loading and its effect on liposomal structure (Figure 3).
Figure 3A,B confirm at hydrophobic nanopar icles are incorporated into the lipid bilay r. Th high
contrast of magnetic nanoparticles made visualizatio of the bilayer extrem ly difficult. However, the
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disposition of the nanoparticles in circular structures not would be observed if nanoparticles were
not embedded into the bilayer. It is known that nanoparticles can disrupt vesicle formation under
certain conditions, for example, when the diameter of hydrophobic nanoparticles is well above the
thickness of the bilayer. In such a case, the lipid of liposomes tends to adsorb around the nanoparticles
resulting in micelle-like structures instead of vesicles [29,30]. Contrarily, if the nanoparticles were of
smaller diameter, the adsorption of lipid around the particles would lead to an excessive curvature. To
avoid this, nanoparticles embed into the bilayer. Other studies that have also incorporated iron oxide
nanoparticles into the bilayers [31,32] shown this kind of interaction.
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Theoretical studies have defined the mechanism of particle embedding as a result between
the reduction of the energy of Gibbs obtained by moving a hydrophobic sphere from water into a
hydrophobic milieu (∆Gsolv) and the increase of energy of Gibbs produced in the deformation of the
bilayer (∆Gdef) [28]. In a system similar to the one used by us (nanoparticles of 5.5 nm of diameter
and liposomes of dioleylphosphatidylcholine [29]) it was calculated that ∆Gsolv is nearly an order of
magnitude greater than ∆Gdef.
In our micrographs, the majority of nanoparticles are concentrated on one side of the vesicle giving
some structures with appearance of Janus-type particles. This behavior has been also observed when
hydrophobic gold nanoparticles were self-assembled with liposomes [33]. These authors indicated that
the presence of nanoparticles in the bilayer results in a membrane deformation and separation, which
establishes a void volume around the nanoparticle within the bilayer. Consequently, the nanoparticles
cluster into the lipid bilayer in order to reduce the void space that surrounds them. This would explain
the formation of the Janus-type nanoparticle vesicle-hybrid. Concerning the hydrophilic nanoparticles
(Figure 3C,D), we observed that the size of liposomes encapsulating such nanoparticles is lesser than
when liposomes were prepared with hydrophobic nanoparticles. The sonication step, although similar
for both types of liposomes, produce vesicle populations of different sizes. According Michel et al. [34],
in those systems formed by hydrophilic nanoparticles and fluid liposomes, where the interactions
between membranes and nanoparticles are sufficiently attractive, when the radius of the particle is
much smaller than the radius of the vesicle, the particle can either decorate the vesicle surface or be
engulfed inside it. In the case of hydrophilic nanoparticles, their size is too small (below a critical
radius that depends on the adhesion energy as well as on the value of the bilayer mean bending
modulus) to be internalized inside the vesicles. We can observe that because the total adhesion energy
does not overcome the energy needed for invagination, a large number of nanoparticles stay outside
the liposome and form clusters. The obtained value of the hydrodynamic size for these liposomes
corresponds indeed to the generated clusters—and not to the individual liposomes—as indicated by
the obtained images.
2.2. Magnetic Resonance (MR) Contrast Properties
The MR contrast properties of the magnetoliposomes were evaluated in vitro using 0.5% agar
phantoms (T1 « 2630 ms and T2 « 210 ms at 7 T) which simulate tumor tissues. The phantoms
contained several types of hybrid nanoparticles (magnetoliposomes with different lipid composition
and two different magnetic nanoparticles). The transversal (T2) relaxation times were measured
with different amounts of magnetoliposomes. Although compounds bearing superparamagnetic
nanoparticles are almost exclusively T2 contrast agents [35], for comparison, longitudinal (T1)
relaxation times were also determined. Magnetic resonance relaxation behavior of water protons
in the presence of contrast agent in phantoms was characterized by linear relationships between iron
concentration and the inverse of proton relaxation times. The slopes of the straight lines indicated
different longitudinal and transverse relaxivities. In this way, the relaxivities of non-liposomal magnetic
nanoparticles were determined to be r1 = 0.96 mM´1¨ s´1 and r2 = 74.5 mM´1¨ s´1 (r2/r1 « 78) for
hydrophilic magnetic nanoparticles, and r1 = 0.80 mM´1¨ s´1 and r2 = 50.7 mM´1¨ s´1 (r2/r1 « 63)
for hydrophobic magnetic nanoparticles, the concentration being expressed in iron. It is well-known
that the relaxivity ratio of r2/r1 is an important parameter to estimate the efficiency of T2 CA. The
hydrophobicity/hydrophilicity of the coatings has an impact on the diffusion of water within the
coating layer. Concerning the nanoparticles used, the hydrophilic ones afford relaxivities that are
higher than those of hydrophobic ones. The presence of oleic acid excludes water molecules around
the magnetic core, and, in consequence, extends the distance of water molecules from the core. As
relaxivities are strongly affected by the distance between the aqueous medium and the magnetite core,
the resulting relaxivities are lower.
It is difficult to compare these values with those reported for the commercial Resovist and Feridex,
which are in the range of 7–14, since these values correspond to a magnetic field strength of 1.5 T [9].
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Unlike the conventional paramagnetic contrast agents, i.e., gadolinium chelates, superparamagnetic
nanoparticles have strong magnetic field strength dependency, and, for this reason, comparison of
relaxivities must be always carried out at the same magnetic field strength. In this way, the values of
relaxivities of the nanoparticles used in this study can be compared with those obtained at the same
magnetic field strength with other superaparamagnetic nanoparticles employed by our group. In
this way, magnetic particles of approximately 12 nm of diameter coated with polyethylenglycol of
4000 Da [36] gave the following values: r1 = 0.68 mM´1¨ s´1 and r2 = 311.1 mM´1¨ s´1; a commercial
ferrofluid of similar size, stabilized with dextran (Micromod), gave r1 = 0.68 mM´1¨ s´1 and
r2 = 337.4 mM´1¨ s´1. The highest r2 relaxivity values of these samples in comparison with the
nanoparticles used in this study are due to the larger size of the magnetic core (12 nm vs. 5 nm), since
the T2 contrast is enhanced not only by the magnetic field strength but also by the radius of iron oxide
core [35]. In other words, the capability of MRI signal enhancement by nanoparticles correlates directly
with the particle size [37].
Table 2 shows both types of relaxivities for the liposomal formulations used. As expected, r1 is
poorly sensitive to concentration of iron oxide nanoparticles at 7 T due to the reduced susceptibility to
dipolar contributions at high field, as well as the presence of bulky surface groups hindering the surface
accessibility of water to the magnetic cores [38]. Contrarily, due to the superparamagnetic nature of
magnetite cores, the transversal relaxivities are highly sensitive to the presence of any substances
around the magnetic core.
Table 2. r1, r2 and r2/r1 ratio of magnetic hydrophilic (H) and hydrophobic (O) nanoparticles
encapsulated into liposomes of different lipid composition. MLs: Magnetoliposomes.
MLs r1/mM´1¨ s´1 r2/mM´1¨ s´1 r2/r1
H-DMPC 9.1 1282 140
O-DMPC 0.9 340 378
O-DMPC-CHOL 0.8 230 288
O-DMPC-PS 0.8 798 ~1000
H-DOPC 3.4 678 199
O-DOPC 0.9 630 700
O-DOPC:CHOL 0.9 281 312
O-DOPC-PS 0.9 995 ~1000
Values of r2 are higher for all the as-synthesized formulations compared with magnetic
nanoparticles alone. The chemical characteristic of any liposomal surface facilitates the adsorption
of a water layer around the liposome and avoids the free diffusion of these molecules towards the
magnetic core resulting in high relaxivity of liposomal formulations. The maximal value of r2 was
obtained with liposomes of DMPC and hydrophilic nanoparticles. As we have observed in microscopic
images, hydrophilic nanoparticles tend to cluster, reducing the access of water molecules to the
nanoparticles’ surfaces and greatly increasing the microscale magnetic inhomogeneity of the sample.
For this reason, the visualization of the effect of the different components will be limited to those
formulations containing hydrophobic nanoparticles. First, we can observe that the lipid composition
affects the MRI properties. Figure 4 shows the inverse of spin-spin proton relaxivities times for DMPC
and DOPC liposomes containing the same hydrophobic nanoparticles. Relaxivity values of DOPC
liposomes are almost 2-fold of those obtained with DMPC liposomes. In this case, the only difference
between such formulations is the length of the lipid acyl chain and the degree of lipid saturation. In this
way, the r2 relaxivity of liposomes with unsaturated phospholipids (DOPC) is higher compared to those
with saturated lipids (DMPC). This fact can be due to the different accessibility of water to the magnetic
core. The same tendency was observed when the formulation contained negative charge (PS) (Table 2).
In general, the embedding of hydrophobic nanoparticles in liposomes leaded to an r2/r1 ratio higher
than that obtained with non-embedded nanoparticles. As indicated previously, the nanoparticles
become confined to a part of the bilayer (like a magnetic Janus-particle) so that each liposome acts as a
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highly magnetizable particle. After subjecting the particle to an external magnetic field, it is able to
locally acquire a magnetic moment comparable to the sum of the magnetic moments of each individual
encapsulated magnetic core. It is noteworthy to mention that magnetoliposomes with PS presented the
highest values of r2/r1 ratio. We observed that the presence of PS in a liposomal formulation produced
a reduction in size in comparison with the non-charged liposomes [39]. Assuming that this reduction is
due to more compaction of the lipid chains, the movement of the water molecules will be also affected
by the presence of PS. Finally, insertion of CHOL into the bilayer seems to reduce the relaxivity values.
This tendency was also observed in a study using liposomes of soybean phosphatidylcholine and
CHOL [40], and was also reported in magnetoliposomes of different lipid composition, but at lower
magnetic field strengths [41]. Notwithstanding the above, considering the differences between the
composition of the liposomes used in the above studies and the composition of those employed by us,
it is probably not viable to make a direct comparison between these two kinds of formulations here
and extract conclusions about the effect of CHOL.
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2.3. Stability of Liposo al Sa ples
The size of the agnetoliposo es as deter ined after their incubation ith isotonic saline or
cell culture ediu for 24 and 48 h. o significant differences ere observed bet een the sa ples
at roo te perature and those kept at 4 ˝ . agnetoliposo es incubated ith culture ediu
aggregated. Their size after 24 h of incubation was almost double their value at time 0. The aggregation
of pristine liposomes in the presence of serum components is a well-known common feature. It is
widely proven that biomolecules, especially proteins, are attached to the surface of nanoparticles
after their incubation with a biological milieu. These biomolecules form a dynamic shell known as
protein corona [42]. However, for biomedical applications it is necessary that the surface coating of the
nanoparticles presents anti-biofouling properties so that the nanoparticles are efficiently directed to the
region of interest. The decoration of nanoparticles with polyethylene glycol (PEG) has been recognized
as the strategy of choice, but recent studies have reported that PEGylation cannot entirely avoid the
protein adsorption, although the degree of corona formation is undoubtedly diminished [43].
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It is important to point out that magnetoliposomes with embedded hydrophobic nanoparticles
present surface regions of a certain hydrophobicity (the hydrophobic part of any Janus-type
nanoparticle), and such regions can attract very few plasma proteins. Hence, the liposome surface
can be surrounded by a differential display of proteins depending on the presence or absence of
hydrophobic nanoparticles in the bilayer. Magnetoliposomes incubated with isotonic saline did
not show significant changes in their size (Figure 5). Average diameters remained unaltered after
24–48 h of incubation, which confirmed the good colloidal stability of the liposomes in the presence of
sodium chloride.
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Figure 5. Change in the average diameter of four liposomal formulations after incubation with
isotonic saline. The bar shows the size immediately after the mixing of the liposomes with saline.
The value of the size after 24 and/or 48 h is marked with a dot. Magnetic hydrophilic (H) and
hydrophobic (O) nanoparticles; DMPC: 1,2-Dimyristoyl-sn-glicerol-3 phosphatidylcholine; DOPC:
1,2-Dioleyl-sn-glicerol-3 phosphatidylcholine.
3. Materials and Methods
3.1. Chemicals and Materials
All chemicals were reagent-grade and used without purification. SPIO magnetite nanoparticles
(5 nm, 5 mg/mL) dispersed in toluene and SPIO magnetite nanoparticles (5 nm, 5 mg/mL) dispersed
in water were purchased from Sigma-Aldrich (St. Louis, MO, USA). Based on the density of magnetite
(5.1 g/cm3), 5 mg/mL is equivalent to 9.4 ˆ 1016 particles/mL. CHOL, 1,2-Dimyristoyl-sn-glicerol-3
phosphatidylcholine (DMPC), and 1,2-Dioleyl-sn-glicerol-3 phosphatidylcholine (DOPC) were
purchased from Sigma-Aldrich (St. Louis, MO, USA). Phosphatidylserine (PS) was purchased from
Lipid Products (Redhill, Surrey, UK). Ultrapure water at 18.2 mΩ was obtained from a Millipore
purification system (Millipore, Bedford, MA, USA) and used in all experiments.
3.2. Preparation of Magnetoliposomes
Magnetoliposomes (MLs) were prepared according Chen et al. [44]. The lipid compositions
were DMPC, DMPC:CHOL (2:1, molar ratio), DMPC:PS (9:1, molar ratio), DOPC, DOPC:CHOL
(2:1, molar ratio), and DOPC:PS (9:1, molar ratio), at 10 mM lipid concentration. The lipid molecule to
nanoparticle (L/N) ratio was approximately of 10,000:1. For obtaining hydrophobic magnetoliposomes
(O-MLs), lipid (367 µL) and hydrophobic magnetic nanoparticles (402 µL) were mixed and placed in
a round-bottom flask. Organic solvents were removed by rotary evaporation at 37 ˝C and reduced
pressure for 45 min. Once the solvent was removed, the resulting lipid/nanoparticles film was hydrated
with 1 mL of water. For hydrophilic magnetoliposomes (H-MLs), lipid (367 µL) was previously
evaporated, and afterwards, the lipid was hydrated with 1 mL of an aqueous suspension of hydrophilic
suspension of magnetic nanoparticles (2.01 mg/mL). After complete hydration, both suspensions
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(O-MLs and H-MLs) were sonicated in two steps. First, a gentle sonication in a bath sonifier (Transonic
Digitals, Elma, Germany) for 30 min, and, then, five sonication steps of 10 s carried out in an UP200St
ultrasonic processor (Hielscher, Teltow, Germany). The separation of liposome-encapsulated and free
SPIONs was accomplished by gel exclusion chromatography (GEC). To this aim, 250 µL of MLs were
applied to a 2.5-mL syringe filled with Sepharose 4B CL. After elution with water, MLs were separated
from non-encapsulated ferrofluid. To exclude the possibility that hydrophilic SPIONs aggregate and
co-elute with liposomes during GEC, free SPION dispersions were treated by the identical procedure
used for ML formation (without addition of lipids) and assessed by GEC.
3.3. Characterization
The hydrodynamic diameter and the corresponding polydispersity index (PI) of MLs were
determined by dynamic light scattering at a fixed scattering angle of 90˝ with a Zetasizer Nano
(Malvern, UK) at 25 ˝C. MLs from the stock solution were dispersed in water to obtain approximately
0.1 g¨L´1 solid content. Geometry of MLs was observed by transmission electron microscopy (TEM)
and cryo-TEM. For TEM observations, a Jeol 1010 microscope (Jeol, Tokyo, Japan) operating at 80,000 kV
was used. Samples were prepared by placing a drop of MLs onto a 400-mesh copper grid coated with
carbon, and after staining with uranyl acetate they were allowed to dry in the air before placing into the
microscope. Images were recorded with a Megaview camera. Acquisition was accomplished with the
Soft-Imaging software (SIS, Münster, Germany). For cryo-TEM observations, grids were transferred to
a Tecnai F20 (FEI, Eindhoven, The Netherlands) using a cryoholder (Gatan, Warrendale, PA, USA).
Images were taken at 200 kV, at a temperature ranging from ´175 to ´170 ˝C and using low-dose
imaging conditions with a 4096 ˆ 4096 pixel CCD Eagle camera (FEI, Eindhoven, The Netherlands).
3.4. Quantification of Iron and Lipid Content
The iron content of MLs was determined by visible spectrophotometry on the basis of the ferrous
ion using o-phenanthroline [45]. The calibration curve was performed with a solution of Fe3O4
(Aldrich, Milwaukee, WI, USA) in 12 mmol¨L´1 HCl. The phospholipid content was determined by
the Steward-Marshall method [46]. The calibration curve was performed with the same different lipid
mixtures in chloroform that the used in the study. Absorbance was measured in a Shimadzu UV-2401
PC UV-vis spectrophotometer (Shimadzu, Kyoto, Japan).
3.5. Determination of the Relaxivity
MRI experiments were conducted on a 7.0 T BioSpec 70/30 horizontal animal scanner (Bruker
BioSpin, Ettlingen, Germany). T1 relaxometry maps were acquired by using RARE (rapid acquisition
with rapid enhancement) sequence applying nine repetition times. For the T2 relaxometry maps,
MSME (multi-slice multi-echo) sequence was used with a repetition time = 4764.346 ms with 16 echo
times. The relaxation rates, R1 = 1/T1 and R2 = 1/T2 for each sample were processed using the
Paravision 5.1 software (Bruker, BioSpin, Ettlingen, Germany). The relaxivity for a MRI CA is defined
as the increase of the relaxation rate of the solvent (water) induced by 1 mmol¨L´1 of the active ion
and it is calculated according to Equation (4):
ripobsq “
«
1
Tipobsq
´ 1
Tipwaterq
ff
{cFe (4)
Herein, i = 1 or 2, and cFe is the analytical iron concentration as determined by the o-phenanthroline
reaction. The relaxivities were computed using linear regression analysis to fit relaxation rates and
molar iron concentrations.
To avoid particle aggregation during the period in which the magnetic field is applied, MLs and
SPIONs were prepared by diluting them in air bubble-free agar phantoms. Ultra-pure agar solution
was made at 75 ˝C. To remove air bubbles, nitrogen gas was flushed through the agar, and vacuum
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suction was applied. Then, the suspension was allowed to cool slowly to approximately 37 ˝C, and
agar was mixed with MLVs or ferrofluid, and the mixing was placed in a 96-wells culture plate. The
iron concentrations ranged from 0.17 to 0.49 mM.
3.6. Stability of Liposomal Samples
The stability of several liposomal samples over time was evaluated by determining the change
in their hydrodynamic diameter for a period of 24–48 h. Aliquots (50 µL) of purified DOPC- and
DMPC-liposomes containing either hydrophobic or hydrophilic nanoparticles were diluted with 3 mL
of isotonic saline or cell culture medium (Dulbecco’s modified Eagle Medium (DMEM) with 10% fetal
calf serum) and kept at room temperature and in a freezer in quiescent conditions.
4. Conclusions
We have characterized superparamagnetic liposomes with saturated DMPC and unsaturated
DOPC phospholipids, and with or without CHOL or PS. The incorporation of hydrophilic or
hydrophobic magnetic particles in the DMPC- or DOPC-based liposomes resulted in hybrid structures
with higher transverse relaxation rates (r2) compared with naked magnetic nanoparticles. The main
reason for this was that the diffusion coefficient of water near the nanoparticles was reduced. The
liposomal coating thus ensured a longer interaction between the water protons and the magnetic
field at the surface of the magnetic core than in absence of coating. Cryogenic electron transmission
microscopy revealed effective embedding of hydrophobic magnetic particles into the bilayer, producing
asymmetric structures similar to Janus-type nanoparticles, since nanoparticles were observed to cluster
in a part of the bilayer. This finding renders cluster-liposome hybrids particularly promising candidates
for MRI applications. In regards to the hydrophobic nanoparticles, the relaxivity of liposomes with
unsaturated phospholipids was higher than that of those with saturated lipids. CHOL led to a smaller
reduction in relaxivity. The highest relaxivity was obtained for magnetoliposomes containing PS.
In general, it is feasible to use magnetoliposomes as negative contrast agents for MRI, making
these nanosystems good candidates to be taken into consideration for molecular imaging. The contrast
is particularly enhanced when hydrophobic nanoparticles are used, since, in this case, due to the
uniform size and high crystallinity of the nanoparticles, there was an additional clustering effect into
the bilayer. Because of these facts, high values of r2 are obtained. Furthermore, the diffusivity of
the water in the coating can be modulated by changing the liposome composition (charge, degree
of saturation, length of the hydrocarbon chain, and presence or absence of CHOL). These hybrid
structures can be administered intravenously and due to the absence of steric stabilizers, e.g., PEG,
they are metabolized by cell of the mononuclear phagocyte system (MPS), accumulating in liver, spleen,
and bone marrow. In this way, these magnetoliposomes can be used for tumor detection, especially in
liver diseases.
Magnetic nanoparticles decrease the magnetic resonance signal intensity due to the uptake by
kupffer cells. Therefore, the image of the tissue appears dark. However, tumor lesions reduce the
uptake and the image of the tissue appears bright relative to the surrounding tissue. Thus, magnetic
particles produce a strong contrast between normal and abnormal liver, thereby enabling clear detection
of the abnormal tissue.
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